文献速递血栓与止血

中央型肺栓塞患者的临床特征与预后

Clinical characteristics and prognosis of patients with central pulmonary embolism.
PubMed 文献 · J Thromb Haemost · 2025-02-14

基于前瞻性SWITCO65+队列回顾性分析597例急性肺栓塞患者,217例(36.3%)为中央型肺栓塞。中央型肺栓塞与随访期间复发性静脉血栓栓塞风险升高相关(亚风险比2.22,95%CI 1.25-3.91),但与总体死亡率无关。

要点

  • 中央型肺栓塞占36.3%,呼吸窘迫症状、右心室功能障碍和心肌损伤更常见
  • 3个月时复发性静脉血栓栓塞、总体/肺栓塞相关死亡率和生活质量无差异
  • 中位随访29.6个月,中央型肺栓塞与复发性静脉血栓栓塞风险升高相关(亚风险比2.22)

核心结论

  • 中央型肺栓塞与非中央型肺栓塞相比,复发性静脉血栓栓塞风险增加约2.2倍。
  • 延长抗凝疗程能否降低中央型肺栓塞后的复发风险有待进一步研究。

研究设计与样本

  • 回顾性分析前瞻性SWITCO65+队列中2009年9月至2013年12月期间的597例急性肺栓塞患者。
  • 中央型肺栓塞定义为肺动脉干或左/右肺动脉内的栓子。
  • 比较中央型与非中央型肺栓塞患者的基线临床特征及3个月和整个随访期间的结局。
  • 分析肺栓塞定位与复发性静脉血栓栓塞及总体死亡率的关联,校正包括溶栓、抗凝期间和非静脉血栓栓塞相关死亡的竞争风险等多重混杂因素。

主要发现

  • 共217例(36.3%)患者为中央型肺栓塞。
  • 中央型肺栓塞患者呼吸窘迫症状/体征、右心室功能障碍和心肌损伤更为常见。
  • 3个月时复发性静脉血栓栓塞、总体/肺栓塞相关死亡率和肺栓塞相关生活质量在两组间无差异。
  • 中位随访29.6个月,中央型肺栓塞患者致命性肺栓塞风险更高(5.5% vs 2.1%;P=0.033)。
  • 校正后,中央型肺栓塞与随访期间复发性静脉血栓栓塞相关(亚风险比2.22;95%CI 1.25-3.91),但与总体死亡率无关(风险比0.74;95%CI 0.45-1.21)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of central localization of pulmonary embolism (PE) on clinical outcomes is uncertain. OBJECTIVES: To compare clinical presentation, risk factors, and outcomes between patients with central pulmonary embolism (cPE) and non-cPE. METHODS: We retrospectively analyzed 597 patients with acute PE from the prospective SWITCO65+ cohort between September 2009 and December, 2013. cPE was defined as an embolus in the pulmonary trunk or the left or right pulmonary artery. We compared baseline clinical characteristics and outcomes at 3 months (recurrent venous thromboembolism [VTE], overall/PE-related mortality, PE-related quality of life) and over the entire follow-up (recurrent VTE, overall/PE-related mortality) between patients with cPE vs non-cPE. We examined the association between PE localization and recurrent VTE and overall mortality, adjusting for multiple confounders including thrombolysis, periods of anticoagulation, and competing risk of non-VTE-related death if appropriate. RESULTS: Overall, 217 (36.3%) patients had cPE. Symptoms/signs of respiratory distress, right ventricular dysfunction, and myocardial injury were more prevalent in those with cPE. VTE recurrence, overall/PE-related mortality, and PE-related quality of life at 3 months did not vary by PE localization. After a median follow-up of 29.6 months, patients with cPE had a higher risk of fatal PE (5.5% vs 2.1%; P = .033). After adjustment, cPE was associated with recurrent VTE (subhazard ratio, 2.22; 95% CI, 1.25-3.91) but not with overall mortality (hazard ratio, 0.74; 95% CI, 0.45-1.21) during follow-up. CONCLUSION: cPE was associated with a 2.2-fold increased risk of recurrent VTE compared to non-cPE. Whether an extended anticoagulation duration could reduce the recurrence risk following cPE should be further examined.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Hofstetter RV, Stalder O, Tritschler T, et al. Clinical characteristics and prognosis of patients with central pulmonary embolism. J Thromb Haemost. 2025. PMID: 39956430. doi:10.1016/j.jtha.2025.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。